The Official Website of the Long-Term Investor
Results 31 - 40 of 1450 : Previous 1 2 3 4 5 6 7 8 9 Next
This Just In: Upgrades and Downgrades
Why doesn't MKM like Lilly?
BioSante Shares Crushed by Placebo Effect
BioSante's LibiGel efficacy is not deemed statistically significant.
Merck Chief Defends $8B R&D Budget As Vital Long-Term Investment
Is this the right direction for pharma to be going in?
Dividend? Buyback? Here's How to Get Both.
But will there be enough to replenish the pipeline?
2 Positive Signs for Eli Lilly
These two simple metrics can save you a lot of pain.
How Does Johnson & Johnson Boost its Returns?
Break it down with the DuPont formula.
Are these stocks ready to take on the market in a rubber match?
Is Sanofi the Right Stock to Retire With?
Stocks that give retirees what they want are incredibly valuable.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK